NCT05797246 2026-01-26Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)National Institutes of Health Clinical Center (CC)Phase 2 Active not recruiting21 enrolled
NCT02759588 2023-01-05GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerGenelux CorporationPhase 1/2 Completed46 enrolled